AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Syntara’s (ASX:SNT) SNT-5505 Trial Marks Progress in Myelofibrosis Treatment
December 10, 2024 05:35 PM AEDT| By Team Kalkine MediaHighlights,Interim trial data for SNT-5505 shows promising results for Syntara (SNT).,Improvements observed in symptoms and spleen volume among patients.,The drug shows strong tolerability and potential long-term benefits.,Syntara Ltd (ASX:SNT) has a...
What’s Ahead for ResMed (ASX: RMD) Stock in 2025?
December 10, 2024 03:07 PM AEDT| By Team Kalkine MediaHighlights,ResMed's projected 20.2% earnings growth outpaces the industry average of 15.9%.,The company boasts impressive 18.1% year-over-year cash flow growth.,Growth stocks are often the focal point of investors looking for exceptional returns, as...
Anteris Technologies (ASX:AVR) Subsidiary ATGC Debuts on Nasdaq with US IPO
December 10, 2024 11:27 AM AEDT| By Team Kalkine MediaHighlights,Anteris,subsidiary launches IPO for Nasdaq listing,.,Proceeds,to fund heart valve development and global studies,.,Maintains,connection to Australian roots via dual listing,.,Anteris Technologies (ASX:AVR), an Australian-based leader in st...
Visioneering Technologies Announces Voluntary Delisting from ASX
December 10, 2024 11:19 AM AEDT| By Team Kalkine MediaHighlights:,Visioneering Delists After Seven Years,Visioneering Technologies (,ASX:VTI,), a US-based eyecare company, will voluntarily delist from the Australian Securities Exchange (ASX) after seven years of offering Chess Depository Interests (CDIs...
Sonic Healthcare Boosts European Presence with German Laboratory Acquisition
December 09, 2024 01:51 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) to acquire Laboratory Group Dr. Kramer & Colleagues in Germany.,Deal valued at €423 million, combining cash payment and share issuance.,Acquisition strengthens Sonic's footprint in Germany and Europe.,Sonic Healthcar...
Terragen Holdings Sees Share Price Surge Following Successful Equity Raising
December 09, 2024 11:55 AM AEDT| By Team Kalkine MediaHighlights,Share Price Surge,: Terragen Holdings experienced a,38.9% jump,in its share price, reaching,5 cents,during early trading hours on December 9, 2024.,Equity Raising Success,: The company successfully raised,$4.76 million,in gross proceeds fr...
Recce Pharmaceuticals Advances Phase 3 Trial for Diabetic Foot Infection Gel in Indonesia
December 09, 2024 11:34 AM AEDT| By Team Kalkine MediaHighlights,Milestone Approval,: Recce Pharmaceuticals gains Indonesian regulatory and ethics approval for Phase 3 trial of its gel, RECCE 327 (R327G).,Focus on Diabetes,: Indonesia’s diabetes crisis underscores the urgency, with nearly 20 million aff...
Sonic Healthcare Expands in Europe with €423M Acquisition of German Lab Group
December 09, 2024 11:30 AM AEDT| By Team Kalkine MediaHighlights,Major Acquisition,: Sonic Healthcare Ltd acquires Laboratory Group Dr. Kramer & Colleagues (LADR), one of Germany's top five medical lab groups.,Strategic Value,: LADR’s expected CY 2024 revenue is €370 million (~AU$610 million), aligning...
Recce Pharmaceuticals (ASX:RCE) Gains Phase 3 Trial Approval in Indonesia
December 09, 2024 11:22 AM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals (RCE) receives approval for a Phase 3 trial in Indonesia targeting diabetic foot infections.,Indonesia's rising diabetes rates make it a strategic location for Recce's innovative treatment.,The trial builds on the com...
ResMed (ASX: RMD) Shares Growth: What’s Driving the Success?
December 06, 2024 03:31 PM AEDT| By Team Kalkine MediaHighlights,ResMed’s revenue grew 12% in FY24, bolstered by its obstructive sleep apnoea (OSA) products.,Patient enrolment in ResMed’s myAir app surged 28% year-over-year, driving growth.,Analysts project 20% earnings growth by FY27, with ResMed tradi...
ASX 200 Mining Stocks Struggling in 2024, But What’s Ahead for 2025?
December 06, 2024 03:19 PM AEDT| By Team Kalkine MediaHighlights,ResMed’s revenue grew 12% in FY24, bolstered by its obstructive sleep apnoea (OSA) products.,Patient enrolment in ResMed’s myAir app surged 28% year-over-year, driving growth.,Analysts project 20% earnings growth by FY27, with ResMed tradi...
CleanSpace Holdings Shares Jump 15.7% Following CEO Appointment Announcement
December 06, 2024 12:04 PM AEDT| By Team Kalkine MediaHighlights,Share Price Surge:,CleanSpace Holdings climbed 15.7% to 40.5 cents during morning trading on Friday.,New CEO Announcement:,Gabrielle O’Carroll, a seasoned executive with 18 years at 3M, will assume the role of CEO starting January 1, 2025....
AstraZeneca Orders Four More APAS Units from Clever Culture Systems
December 05, 2024 07:48 PM AEDT| By Team Kalkine MediaHighlights,AstraZeneca orders four more microbiological scanners from Clever Culture Systems.,The $3M order includes seven years of support and maintenance.,APAS system integration expands across AstraZeneca’s global operations.,In a significant deve...
Memphasys Ships Felix Sperm Separator Unit to Dubai
December 05, 2024 02:24 PM AEDT| By Team Kalkine MediaHighlights:,Memphasys,Ltd. (,ASX:MEM,),has delivered a demonstration unit of its Felix sperm separator system to a Dubai hospital for evaluation.,The Felix system,utilizes,electrophoresis technology to isolate sperm from semen for artificial insemina...
Island Pharmaceuticals Advances Dengue Fever Treatment with Promising PROTECT Clinical Trial Results
December 05, 2024 01:23 PM AEDT| By Team Kalkine MediaHighlights:,Encouraging Progress in Dengue Research:,Island Pharmaceuticals (,ASX:ILA,) has announced promising results from its PROTECT clinical trial, targeting the prevention and treatment of Dengue fever, which affects 400 million people annually...
Clever Culture Systems Lands $3M Order from AstraZeneca, Shares Surge 23.53%
December 05, 2024 01:11 PM AEDT| By Team Kalkine MediaHighlights,AstraZeneca Order Expansion:,AstraZeneca’s latest order brings the total number of APAS units purchased to 12.,APAS Technology:,The system automates imaging and analysis of microbiological cultures on laboratory plates and was first offere...
Lumos Diagnostics Shares Surge 22.6% on Milestone Approval for FebriDx Reimbursement
December 05, 2024 12:47 PM AEDT| By Team Kalkine MediaHighlights,CMS Approval:,FebriDx received a PLA code (0442U) with reimbursement set at US$41.38 per test, effective January 2025.,Unique Diagnostic Tool:,FebriDx distinguishes bacterial from non-bacterial infections, addressing antibiotic overprescri...
AstraZeneca Expands Partnership with Clever Culture Systems (ASX:CC5) Through $3M APAS Order
December 05, 2024 11:29 AM AEDT| By Team Kalkine MediaHighlights:,Clever Culture Systems Secures AstraZeneca Order:,AstraZeneca placed an order for four,additional,APAS microbiological scanners from Clever Culture Systems (ASX:CC5) valued at $3 million over seven years, including maintenance and support...
Anatara’s IBS Treatment Trial Achieves Key Recruitment Milestone
December 04, 2024 02:58 PM AEDT| By Team Kalkine MediaHighlights,Anatara,Lifesciences (ANR) completes participant recruitment for Stage 2 of its IBS treatment trial,.,Recruitment spans four sites across Australia with screening set to continue,.,Headline results,anticipated,in the first quarter of 2025,...
Invion Begins Clinical Trials for Promising Skin Cancer Treatment INV043
December 03, 2024 12:24 PM AEDT| By Team Kalkine MediaHighlights,Invion,(IVX),commences,trials for its advanced cancer treatment, INV043,.,The trial explores non-invasive therapy for non-melanoma skin cancer,.,Pre-clinical research suggests potential benefits of INV043 in cancer treatment,.,Invion (ASX:...
Advertise your brand on Kalkine Media